Professor Jason White

Emeritus Professor UniSA Clinical & Health Sciences

City East Campus (P1-13)
tel +61 8 830 21203

email Jason.White@unisa.edu.au

Research Degree Supervisor

About me

Jason White is an Adjunct Professor in the School of Pharmacy and Medical Sciences, University of South Australia. He qualified from the University of Adelaide with a BSc (Hons) and a PhD, received post-doctoral training in pharmacology at Emory University and subsequently held academic positions at Monash University, the University of Adelaide and at the University of South Australia from 2010 to 2018 as Professor of Pharmacology and Head of the School of Pharmacy and Medical Sciences. Prof White has published extensively in the pharmacology of addictive drugs and in the treatment of drug and alcohol dependence, and attracted numerous research grants and contracts from NHMRC, NIH, government and industry. In... Read more

UniSA Clinical & Health Sciences

UniSA Clinical & Health Sciences is addressing society’s most critical and emerging health needs through quality teaching, learning and research excellence.

Tweets by @UniversitySA

Research

Research focus

Psychology
Public Health and Health Services
Pharmacology and Pharmaceutical Sciences
Clinical Sciences
Medical and Health Sciences

Highlights

Research

Projects

Excludes commercial-in-confidence projects.

Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence, NHMRC - Project Grant, 01/01/2016 - 31/12/2021
Daily sampling at an agreed South Australian regional wastewater treatment plant, Australian Criminal Intelligence Commission, 15/03/2021 - 30/06/2021
Prison Wastewater Sampling and Analysis, SA Dept for Correctional Services, 11/08/2020 - 07/02/2021
Tracking use of novel psychoactive substances in Australia, Thyne Reid Foundation Grant, 20/06/2017 - 31/01/2020
National Waste Water Analysis Pilot, Australian Criminal Intelligence Commission, 01/01/2017 - 30/12/2019
Are young adults aware of the long-lasting consequences of methamphetamine ('ICE') use on all health & would knowledge of a visible long-lasting consequence decrease use of the drug?, Fay Fuller Foundation, 06/03/2017 - 30/06/2019
Waste water analysis to test methamphetamine usage levels, Western Australia Police, 01/08/2015 - 02/08/2018
Research Infrastructure Fund (RIF) Grant 2016 Round 2 - Biofilm Testing Facility, Adelaide Integrated Bioscience Laboratories, 28/11/2016 - 31/12/2017
Waste water analysis to test metabolites of a variety of drugs, Southern Adelaide Health Service, 01/10/2015 - 18/12/2017

Other projects

Randomised double-blind placebo-controlled study of lisdexamfetamine for the treatment of methamphetamine dependence, NHMRC - Project Grant, 2016-2019

Research

Outputs

Research outputs for the last seven years are shown below. Some long-standing staff members may have older outputs included. To see earlier years visit ORCID, ResearcherID or Scopus

Open access indicates that an output is open access.

Chapters

Year	Output
2023	Gerber, C, Jaunay, EL, Simpson, BS & White, JM 2023, 'Moving beyond wastewater analysis toward epidemiology', in Mohammad Hadi Dehghani et al. (eds), Wastewater-Based Epidemiology for the Assessment of Human Exposure to Environmental Pollutants, Academic Press, UK, ch. 2, pp. 33-60. 1
2017	Todd, G & White, J 2017, 'The long-lasting effects of cannabis use on movement and brain regions that control movement', in VR Preedy (ed.), Handbook of cannabis and related pathologies, Academic Press, United Kingdom, ch. 38, pp. 372-378. 1 9
2016	Pearson-Dennett, V, Wilcox, RA, White, JM & Todd, G 2016, 'Movement dysfunction as a neuropathology of illicit stimulant abuse', in VR Preedy (ed.), The neuropathology of drug addictions and substance misuse volume 3: general processes and mechanisms, prescription medications, caffeine and areca, polydrug misuse, emerging addictions and non-drug addictions, Elsevier, UK, ch. 22, pp. 219-228. 1
2009	Gijsbers, A, White, JM & Clark, A 2009, 'LAAM in the treatment of opioid dependence:A systematic review', in Richard P. Mattick, Robert Ali, Nicholas Lintzeris, Pharmacotherapies for the Treatment of Opioid dependence; Efficacy, Cost-Effectiveness, and Implementation Guidelines, Informa Healthcare, US, ch. 5, pp. 142-192.
2009	Ritter, A, Mattick, R, Newton, I, White, JM, Whicker, S, Monheit, B, Bell, J, Henry-Edwards, S, Hawkin, L, Lintzeris, N, Muhleisen, P, Clark, JH, Ali, MM, Linda, R & Quigley, A 2009, 'National clinical guidelines and procedures for the use of buprenorphine in the treatment of heroin dependence', in Richard P. Mattick, Robert Ali, Nicholas Lintzeris, Pharmacotherapies for the Treatment of Opioid dependence; Efficacy, Cost-Effectiveness, and Implementation Guidelines, Informa Healthcare, US, ch. 12, pp. 390-445.
2009	White, JM, La Vincente, S, Hutchinson, M, Gordon, A, Mitchell, T, Newcombe, D, Somogyi, A & Morrish, G 2009, 'Pharmacology of opioid agonists and antagonists', in Richard P. Mattick, Robert Ali, Nicholas Lintzeris, Pharmacotherapies for the Treatment of Opioid dependence; Efficacy, Cost-Effectiveness, and Implementation Guidelines, Informa Healthcare, US, ch. 2, pp. 15-53.
2009	White, JM, Lintzeris, N, Bell, J, Ali, MM, Brough, R, Hendry-Edwards, S, Linda, R, Ritter, A & Quigley, A 2009, 'Clinical guidelines and procedures for the use of methadone in the maintenance treatment of opioid dependence', in Richard P. Mattick, Robert Ali, Nicholas Lintzeris, Pharmacotherapies for the Treatment of Opioid dependence; Efficacy, Cost-Effectiveness, and Implementation Guidelines, Informa Healthcare, US, ch. 11, pp. 354-389.

Journal Articles

Year	Output
2025	Keller, EL, Peake, B, Simpson, BS, White, JM & Gerber, C 2025, 'Comprehensive method to detect nitazene analogues and xylazine in wastewater', Environmental Science and Pollution Research, online, pp. 1-8. Open access 2
2024	Jaunay, EL, Bade, R, Paxton, KR, Nadarajan, D, Barry, DC, Zhai, Y, Tscharke, BJ, O'Brien, JW, Mueller, J, White, JM, Simpson, BS & Gerber, C 2024, 'Monitoring the use of novel psychoactive substances in Australia by wastewater-based epidemiology', Science of the Total Environment, vol. 919, article no. 170473, pp. 1-7. Open access 12 9 92
2024	Jaunay, EL, Simpson, BS, White, JM & Gerber, C 2024, 'Amphetamine-type drug-related fatalities in the context of 8 years of methamphetamine use measured by wastewater analysis in South Australia', Drug Testing and Analysis, vol. 16, no. 10, pp. 1137-1143. Open access 2
2024	Tscharke, B, Livingston, M, O'Brien, JW, Bade, R, Thomas, K V, Mueller, JF, Hall, W, Simpson, BS, Jaunay, E, Gerber, C, White, JM & Thai, PK 2024, 'Seven-years of alcohol consumption in Australia by wastewater analysis: exploring patterns by remoteness and socioeconomic factors', Drug and Alcohol Dependence, vol. 259, article no, 111317, pp. 1-5. Open access 4 4 514
2023	Bade, R, Rousis, N, Adhikari, S, Baduel, C, Gerber, C, Jaunay, E, White, JM & Mueller, JF and 37 other authors 2023, 'Three years of wastewater surveillance for new psychoactive substances from 16 countries', WATER RESEARCH X, vol. 19, article no. 100179. Open access 34 30 100
2023	Jaunay, EL, Simpson, BS, White, JM & Gerber, C 2023, 'Using wastewater-based epidemiology to evaluate the relative scale of use of opioids', Science of the Total Environment, vol. 897, article no. 165148, pp. 1-7. Open access 6 6 1
2023	Thai, PK, Tscharke, BJ, O'Brien, J, Gartner, C, Bade, R, Gerber, C, White, JM, Zheng, Q, Wang, Z, Thomas, K V & Mueller, JF 2023, 'Increased nicotine consumption in Australia during the first months of the COVID-19 Pandemic', Nicotine and Tobacco Research, vol. 25, no. 6, pp. 1194-1197. Open access 4 4 30
2023	Tscharke, BJ, O'Brien, JW, Ahmed, F, Nguyen, L, Ghetia, M, Chan, G, Thai, P, Gerber, C, Bade, R, Mueller, J, Thomas, K V, White, J & Hall, W 2023, 'A wastewater-based evaluation of the effectiveness of codeine control measures in Australia', Addiction, vol. 118, no. 3, pp. 480-488. Open access 7 6 89
2022	Bade, R, White, JM, Ghetia, M, Adiraju, S & Gerber, C and 20 other authors 2022, 'A taste for new psychoactive substances: wastewater analysis study of 10 countries', Environmental Science and Technology Letters, vol. 9, no. 1, pp. 57-63. 38 31 101
2022	Othman, AA, Simpson, BS, Jaunay, EL, White, JM, Bade, R & Gerber, C 2022, 'A method for improved detection of 8-isoprostaglandin F2α/β and benzodiazepines in wastewater', Science of the Total Environment, vol. 851, article no. 158061, pp. 1-10. Open access 3 1 4
2022	Pandopulos, AJ, Simpson, BS, White, JM, Bade, R & Gerber, C 2022, 'Partitioning of phytocannabinoids between faeces and water - implications for wastewater-based epidemiology', Science of the Total Environment, vol. 805, article no. 150269. 10 8 1
2022	Simpson, BS, Jaunay, EL, Ghetia, M, Nguyen, L, Bade, R, White, JM & Gerber, C 2022, 'Methcathinone in wastewater: drug of choice, or artefact?', Science of the Total Environment, vol. 836, pp. 1-5. 12 9 18
2021	Bade, R, Ghetia, M, Chappell, A, White, JM & Gerber, C 2021, 'Pholedrine is a marker of direct disposal of methamphetamine', Science of the Total Environment, vol. 782, pp. 1-5. 7 6 2
2021	Bade, R, Simpson, BS, Ghetia, M, Nguyen, L, White, JM & Gerber, C 2021, 'Changes in alcohol consumption associated with social distancing and self‐isolation policies triggered by COVID‐19 in South Australia: a wastewater analysis study', Addiction, vol. 116, no. 6, pp. 1600-1605. Open access 66 60 33
2021	Bade, R, Tscharke, BJ, O'Brien, JW, Magsarjav, S, Humphries, M, Ghetia, M, Thomas, K V, Mueller, JF, White, JM & Gerber, C 2021, 'Impact of COVID-19 controls on the use of illicit drugs and alcohol in Australia', Environmental Science and Technology Letters, vol. 8, no. 9, pp. 799-804. 31 28 38
2021	Bade, R, White, JM & Gerber, C 2021, 'How the recreational stimulant market has changed: case study in Adelaide, Australia 2016-2019', Science of the Total Environment, vol. 757, article no. 143728. Open access 17 13 5
2021	Bade, R, White, JM, Chen, J, Baz-Lomba, JA, Been, F, Bijlsma, L, Burgard, DA, Castiglioni, S, Salgueiro-Gonzalez, N, Celma, A, Chappell, A, Emke, E, Steenbeek, R, Wang, D, Zuccato, E & Gerber, C 2021, 'International snapshot of new psychoactive substance use: case study of eight countries over the 2019/2020 new year period', Water Research, vol. 193, article no. 116891, pp. 1-12. 44 40 123
2021	Pandopulos, AJ, Bade, R, Tscharke, BJ, O'Brien, JW, Simpson, BS, White, JM & Gerber, C 2021, 'Application of catecholamine metabolites as endogenous population biomarkers for wastewater-based epidemiology', Science of the Total Environment, vol. 763, article no. 142992, pp. 1-8. 21 16 1
2021	Pandopulos, AJ, Simpson, BS, Bade, R, O'Brien, JW, Yadav, MK, White, JM & Gerber, C 2021, 'A method and its application to determine the amount of cannabinoids in sewage sludge and biosolids', Environmental Science and Pollution Research, vol. 28, no. 42, pp. 59652-59664. 15 9 1
2021	Vitry, A, Forte, G & White, J 2021, 'Access to controlled medicines in low-income countries: listening to stakeholders in the field', International Journal of Health Services, vol. 51, no. 3, pp. 404-411. Open access 3 3
2021	Vogel, AP, Pearson-Dennett, V, Magee, M, Wilcox, RA, Esterman, A, Thewlis, D, White, JM & Todd, G 2021, 'Adults with a history of recreational cannabis use have altered speech production', Drug and Alcohol Dependence, vol. 227, article no. 108963 pp. 1-8. 5 3 54
2020	Bade, R, Abbate, V, Abdelaziz, A, Nguyen, L, Trobbiani, S, Stockham, P, Elliot, S, White, JM & Gerber, C 2020, 'The complexities associated with new psychoactive substances in influent wastewater: the case of 4‐ethylmethcathinone', Drug Testing and Analysis, vol. 12, no. 10, pp. 1494-1500. Open access 5 4 15
2020	Bade, R, Abdelaziz, A, Nguyen, L, Pandopulos, AJ, White, JM & Gerber, C 2020, 'Determination of 21 synthetic cathinones, phenethylamines, amphetamines and opioids in influent wastewater using liquid chromatography coupled to tandem mass spectrometry', Talanta, vol. 208, article no. 120479, pp. 1-8. 74 63 6
2020	Bade, R, Ghetia, M, White, JM & Gerber, C 2020, 'Determination of prescribed and designer benzodiazepines and metabolites in influent wastewater', Analytical Methods, vol. 12, no. 28, pp. 3637-3644. Open access 37 33 1
2020	Bade, R, White, JM, Nguyen, L, Pandopulos, AJ & Gerber, C 2020, 'What is the drug of choice of young festivalgoers?', Drug and Alcohol Dependence, vol. 216, article no. 108315, pp. 1-5. Open access 16 12 5
2020	Bade, R, White, JM, Nguyen, L, Tscharke, BJ, Mueller, JF, O'Brien, JW, Thomas, K V & Gerber, C 2020, 'Determining changes in new psychoactive substance use in Australia by wastewater analysis', Science of the Total Environment, vol. 731, article no. 139209, pp. 1-9. Open access 43 37 75
2020	Bade, R, White, JM, Tscharke, BJ, Ghetia, M, Abdelaziz, A & Gerber, C 2020, 'Anabasine‐based measurement of cigarette consumption using wastewater analysis', Drug Testing and Analysis, vol. 12, no. 9, pp. 1393-1398. Open access 14 10
2020	Gerber, C, Bade, R & White, J 2020, 'Amphetamine dependence in Australia', The Lancet, vol. 396, no. 10256, pp. 957. Open access
2020	Pandopulos, AJ, Bade, R, O'Brien, JW, Tscharke, BJ, Mueller, JF, Thomas, K, White, JM & Gerber, C 2020, 'Towards an efficient method for the extraction and analysis of cannabinoids in wastewater', Talanta, vol. 217, article no. 121034, pp. 1-10. 53 45 3
2020	Pandopulos, AJ, Gerber, C, Tscharke, BJ, O'Brien, J, White, JM & Bade, R 2020, 'A sensitive analytical method for the measurement of neurotransmitter metabolites as potential population biomarkers in wastewater', Journal of Chromatography A, vol. 1612, article no. 460623, pp. 1-9. 19 19 1
2019	Athanasos, P, Ling, W, Bochner, F, White, JM & Somogyi, AA 2019, 'Buprenorphine maintenance subjects are hyperalgesic and have no antinociceptive response to a very high morphine dose', Pain Medicine, vol. 20, no. 1, pp. 119-128. Open access 28 27
2019	Bade, R, Ghetia, M, Nguyen, L, Tscharke, BJ, White, JM & Gerber, C 2019, 'Simultaneous determination of 24 opioids, stimulants and new psychoactive substances in wastewater', MethodsX, vol. 6, pp. 953-960. Open access 40 36 4
2019	Bade, R, Stockham, P, Painter, B, Celma, A, Bijlsma, L, Hernandez, F, White, JM & Gerber, C 2019, 'Investigating the appearance of new psychoactive substances in South Australia using wastewater and forensic data', Drug Testing and Analysis, vol. 11, no. 2, pp. 250-256. Open access 36 28 3
2019	Bade, R, Tscharke, BJ, White, JM, Grant, S, Mueller, JF, O'Brien, J, Thomas, K V & Gerber, C 2019, 'LC-HRMS suspect screening to show spatial patterns of new psychoactive substances use in Australia', Science of the Total Environment, vol. 650, pp. 2181-2187. Open access 67 54 1
2019	McDonough, M, Johnson, JL, White, JM & Buisman-Pijlman, FT 2019, 'Measuring opioid dependence in chronic pain patients: a comparison between addiction clinic and pain clinic patient populations', Journal of Opioid Management, vol. 15, no. 4, pp. 285-293. Open access 4
2019	Pajcin, M, Banks, S, Dorrian, J, Gupta, C, Coates, A, Grant, C, White, J & Della Vedova, C 2019, 'Salivary levels of alpha-amylase are associated with neurobehavioral alertness during extended wakefulness, but not simulated night-shift work', Physiology and Behavior, vol. 204, pp. 1-9. Open access 7 5 8
2019	Pajcin, M, White, JM, Banks, S, Dorrian, J, Paech, GM, Grant, CL, Johnson, K, Tooley, K, Aidman, E, Fidock, J, Kamimori, GH & Della Vedova, CB 2019, 'Effects of strategic early-morning caffeine gum administration on association between salivary alpha-amylase and neurobehavioural performance during 50 h of sleep deprivation', Accident Analysis and Prevention, vol 126, pp. 160-172. 4 3 2
2019	Peacock, A, Bruno, R, Gisev, N, Degenhardt, L, Hall, W, Sedefov, R, White, J, Thomas, KV, Farrell, M & Griffiths, P 2019, 'New psychoactive substances: challenges for drug surveillance, control, and public health responses', The Lancet, vol. 394, no. 10209, pp. 1668-1684. 250 212
2019	Pearson-Dennett, V, Faulkner, PL, Collie, B, Wilcox, RA, Vogel, AP, Thewlis, D, Esterman, A, McDonnell, MN, Gandevia, SC, White, JM & Todd, G 2019, 'Use of illicit amphetamines is associated with long-lasting changes in hand circuitry and control', Clinical Neurophysiology, vol. 130, no. 5, pp. 655-665. Open access 4 4 5
2019	Todd, G, Burns, L, Pearson-Dennett, V, Esterman, A, Faulkner, PL, Wilcox, RA, Thewlis, D, Vogel, AP & White, JM 2019, 'Prevalence of self-reported movement dysfunction among young adults with a history of ecstasy and methamphetamine use', Drug and Alcohol Dependence, vol. 205, article no.107595, pp. 1-9. 5 4 8
2018	Bade, R, Tscharke, BJ, Longo, M, Cooke, R, White, JM & Gerber, C 2018, 'Investigating the correlation between wastewater analysis and roadside drug testing in South Australia', Drug and Alcohol Dependence, vol. 187, pp. 123-126. Open access 16 14 2
2018	Bade, R, White, J & Gerber, C 2018, 'Qualitative and quantitative temporal analysis of licit and illicit drugs in wastewater in Australia using liquid chromatography coupled to mass spectrometry', Analytical and Bioanalytical Chemistry, vol. 410, no. 2, pp. 529-542. 45 37 3
2018	Ezard, N, Dunlop, A, Hall, M, Ali, R, McKetin, R, Bruno, R, Phung, N, Carr, A, White, J, Clifford, B, Liu, Z, Shanahan, M, Dolan, K, Baker, AL & Lintzeris, N 2018, 'LiMA: A study protocol for a randomised, double-blind, placebo controlled trial of lisdexamfetamine for the treatment of methamphetamine dependence', BMJ Open, vol. 8, no. 7, article no. e020723, pp. 1-9. Open access 16 14
2018	Hotham, E, Haberfield, M, Hillier, S, White, JM & Todd, G 2018, 'Upper limb function in children with attention-deficit/hyperactivity disorder (ADHD)', Journal of Neural Transmission, vol. 125, no. 4, pp. 713-726. Open access 23 23
2018	Lai, FY, Gartner, C, Hall, W, Carter, S, O'Brien, J, Tscharke, BJ, Been, F, Gerber, C, White, J, Thai, P, Bruno, R, Prichard, J, Kirkbride, KP & Mueller, JF 2018, 'Measuring spatial and temporal trends of nicotine and alcohol consumption in Australia using wastewater-based epidemiology', Addiction, vol. 113, no. 6, pp. 1127-1136. Open access 68 64 6
2018	Stallman, HM, Kohler, M & White, J 2018, 'Medication induced sleepwalking: a systematic review', Sleep Medicine Reviews, vol. 37, pp. 105-113. Open access 85 64
2017	Gowing, L, Ali, R & White, JM 2017, 'Opioid antagonists with minimal sedation for opioid withdrawal', Cochrane Database of Systematic Reviews, vol. 2017, article no. CD002021, pp. 1-46. Open access 38 17
2017	Gowing, L, Ali, R, White, JM & Mbewe, D 2017, 'Buprenorphine for managing opioid withdrawal', Cochrane Database of Systematic Reviews, vol. 2017, no. 2, article no. CD002025, pp. 1-97. Open access 128 112
2017	Newcombe, DA, Somogyi, AA, Bochner, F & White, JM 2017, 'Impaired psychomotor function and plasma methadone and levo-alpha-acetylmethadol (LAAM) concentrations in opioid-substitution patients', Experimental and Clinical Psychopharmacology, vol. 25, no. 3, pp. 223-233. 3 3
2017	Pajcin, M, Banks, S, White, JM, Dorrian, J, Paech, GM, Grant, C, Johnson, K, Tooley, K, Fidock, J, Kamimori, GH & Della Vedova, CB 2017, 'Decreased salivary alpha-amylase levels are associated with performance deficits during sleep loss', Psychoneuroendocrinology, vol. 78, pp. 131-141. Open access 23 23 8
2017	Pearson-Dennett, V, Todd, G, Wilcox, RA, Vogel, AP, White, JM & Thewlis, D 2017, 'History of cannabis use is associated with altered gait', Drug and Alcohol Dependence, vol. 178, pp. 215-222. 12 11 60
2016	Gowing, L, Farrell, M, Ali, R & White, JM 2016, 'Alpha(2)-adrenergic agonists for the management of opioid withdrawal', Cochrane Database of Systematic Reviews, vol. 2016, no. 5, article no. CD002024, pp. 1-88. Open access 99 118
2016	Hotham, ED, Ali, RL & White, JM 2016, 'Analysis of qualitative data from the investigation study in pregnancy of the ASSIST Version 3.0 (the Alcohol, Smoking and Substance Involvement Screening Test)', Midwifery, vol. 34, pp. 183-197. 11 9
2016	Hotham, ED, Ali, RL, White, JM & Robinson, JS 2016, 'Ethical considerations when researching with pregnant substance users and implications for practice', Addictive Behaviors, vol. 60, pp. 242-243. 3 2
2016	Todd, G, Pearson-Dennett, V, Flavel, S, Haberfield, M, Edwards, H & White, JM 2016, 'History of illicit stimulant use is not associated with long-lasting changes in learning of fine motor skills in humans', Neural Plasticity, vol. 2016, no. 9485079, pp. 1-11. Open access 3 3
2016	Todd, G, Pearson-Dennett, V, Wilcox, RA, Minh T Chau, Thoirs, K, Thewlis, D, Vogel, AP & White, JM 2016, 'Adults with a history of illicit amphetamine use exhibit abnormal substantia nigra morphology and parkinsonism', Parkinsonism and Related Disorders, vol. 25, pp. 27-32. Open access 35 31 42
2016	Tscharke, BJ, Chen, C, Gerber, JP & White, J 2016, 'Temporal trends in drug use in Adelaide, South Australia by wastewater analysis', Science of the Total Environment, vol. 565, pp. 384-391. 127 113 54
2016	Tscharke, BJ, White, JM & Gerber, JP 2016, 'Estimates of tobacco use by wastewater analysis of anabasine and anatabine', Drug Testing and Analysis, vol. 8, no. 7, pp. 702-707. 37 31 10
2015	Kershaw, SG, Della Vedova, CB, Majumder, I, Ward, MB, Farquharson, A, Williamson, PA & White, JM 2015, 'Acute opioid administration induces hypothalamic-pituitary-adrenal activation and is mediated by genetic variation in interleukin (Il)1B', Pharmacology Biochemistry and Behavior, vol. 138, pp. 9-13. 6 6 1
2015	Kershaw, SG, Dry, M, Della Vedova, C, Majumder, I, Ward, M, Williamson, P & White, J 2015, 'Inspection time as a general measure of cognitive impairment following acute opioid exposure', Drug and Alcohol Dependence, vol. 156, pp. e108-e108.
2015	Tscharke, BJ, Chen, C, Gerber, JP & White, JM 2015, 'Trends in stimulant use in Australia: a comparison of wastewater analysis and population surveys', Science of the Total Environment, vol. 536, pp. 331-337. 37 38 1
2014	Chen, C, Kostakis, C, Gerber, JP, Tscharke, BJ, Irvine, RJ & White, JM 2014, 'Towards finding a population biomarker for wastewater epidemiology studies', Science of the Total Environment, vol. 487, no. 1, pp. 621-628. 130 115
2014	Gowing, L, Farrell, MF, Ali, R & White, JM 2014, 'Alpha(2)-adrenergic agonists for the management of opioid withdrawal', Cochrane Database of Systematic Reviews, vol. 3, article no. CD002024, pp. 1-85. Open access 86 29
2014	Pearson-Dennett, V, Flavel, SC, Wilcox, RA, Thewlis, D, Vogel, AP, White, JM & Todd, G 2014, 'Hand function is altered in individuals with a history of illicit stimulant use', PLoS One, vol. 9, no. 12, pp. 1-16. Open access 8 8
2013	Chen, C, Kostakis, C, Irvine, RJ & White, JM 2013, 'Increases in use of novel synthetic stimulant are not directly linked to decreased use of 3,4-methylenedioxy-N-methylamphetamine (MDMA)', Forensic Science International, vol. 231, no. 1, pp. 278-283. Open access 53 44
2013	Flavel, SC, White, JM & Todd, G 2013, 'Abnormal maximal finger tapping in abstinent cannabis users', Human Psychopharmacology- Clinical And Experimental, vol. 28, no. 6, pp. 612-614. 8 7
2013	Hotham, E, Ali, R, White, J, Sullivan, T & Robinson, J 2013, 'Investigation of the Alcohol, Smoking, and Substance Involvement Screening Test (the ASSIST) version 3.0 in pregnancy', Addictive Disorders and Their Treatment, vol. 12, no. 3, pp. 123-135. 8 5
2013	Todd, G, Noyes, C, Flavel, S, Della Vedova, CB, Spyropoulos, P, Chatterton, B, Berg, D & White, JM 2013, 'Illicit stimulant use is associated with abnormal substantia nigra morphology in humans', PLoS One, vol. 8, no. 2, article no. e56438. Open access 44 40
2012	Barratt, D, Coller, J, Hallinan, R, Byrne, A, White, JM, Foster, DJR & Somogyi, A 2012, 'ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics', Pharmacogenomics and Personalized Medicine, vol. 5, no. 1, pp. 53-62. Open access 48 42
2012	Chen, C, Kostakis, C, Irvine, RJ, Felgate, PD & White, JM 2012, 'Evaluation of pre-analysis loss of dependent drugs in wastewater: stability and binding assessments', Drug Testing and Analysis, vol. 5, no. 8, pp. 716-721. 55 50
2012	Coller, JK, Michalakas, JR, James, HM, Farquharson, AL, Colvill, J, White, JM & Somogyi, AA 2012, 'Inhibition of CYP2D6-mediated tramadol O-demethylation in methadone but not buprenorphine maintenance patients', British Journal of Clinical Pharmacology, vol. 74, no. 5, pp. 835-841. Open access 22 18
2012	Dry, MJ, Burns, NR, Nettlebeck, T, Farquharson, AL & White, JM 2012, 'Dose-related effects of alcohol on cognitive functioning', PLoS One, vol. 7, no. 11, article no. e50977, pp. 1-8. Open access 116 105
2012	Flavel, SC, Koch, JD, White, JM & Todd, G 2012, 'Illicit stimulant use in humans is associated with a long-term increase in tremor', PLoS One, vol. 7, no. 12, article no. e52025, pp. 1-9. Open access 25 19
2012	Flavel, SC, White, JM & Todd, G 2012, 'Motor cortex and corticospinal excitability in humans with a history of illicit stimulant use', Journal of Applied Physiology, vol. 113, no. 9, pp. 1486́-1494. Open access 20 18
2012	Gelston, E, Coller, JK, Lopatko, O V, James, HM, Schmidt, H, White, JM & Somogyi, AA 2012, 'Methadone inhibits CYP2D6 and UGT2B7/2B4 in vivo: a study using codeine in methadone- and buprenorphine-maintained subjects', British Journal of Clinical Pharmacology, vol. 73, no. 5, pp. 786-794. Open access 27 24
2012	Gordon, A, Lopatko, O, Haslam, R, Stacey, H, Pearson, V, Woods, A, Fisk, A & White, J 2012, 'Ineffective morphine treatment regimen for the control of Neonatal Abstinence Syndrome in buprenorphine- and methadone-exposed infants', Journal of Developmental Origins of Health and Disease, vol. 3, no. 4, pp. 262-270. Open access 11 11
2012	Gordon, AL, Lopatko, O V, Stacey, H, Pearson, V, Woods, A, Fisk, A & White, JM 2012, 'Patterns of symptom reporting during pregnancy comparing opioid maintained and control women', Journal of Addiction Medicine, vol. 6, no. 4, pp. 258-264. 6 4
2012	Hotham, E, White, J, Ali, R & Robinson, J 2012, 'Screening for use of alcohol, tobacco and cannabis in pregnancy using self-report tools', Journal of Developmental Origins of Health and Disease, vol. 3, no. 4, pp. 216-223. Open access 1
2012	Krishnan, S, Salter, A, Sullivan, T, Gentgall, M, White, J & Rolan, P 2012, 'Comparison of pain models to detect opioid-induced hyperalgesia', Journal of Pain Research, vol. 5, pp. 99-106. Open access 28
2012	Majumder, I, White, JM & Irvine, RJ 2012, 'Antidepressant-like effects of ecstasy in subjects with a predisposition to depression', Addictive Behaviors, vol. 37, no. 10, pp. 1189-1192. 18 16
2012	Savvas, SM, Somogyi, AA & White, JM 2012, 'The effect of methadone on emotional reactivity', Addiction, vol. 107, no. 2, pp. 388-392. 21 18
2011	Chen, C, Kostakis, C, Harpas, P, Felgate, PD, Irvine, RJ & White, JM 2011, 'Marked decline in 3,4-methylenedioxymethamphetamine (MDMA) based on wastewater analysis', Journal of Studies on Alcohol and Drugs, vol. 72, no. 5, pp. 737-740. 17 16
2011	Coller, JK, Cahill, S, Edmonds, C, Farquharson, AL, Longo, M, Minniti, R, Sullivan, T, Somogyi, AA & White, JM 2011, 'OPRM1 A118G genotype fails to predict the effectiveness of naltrexone treatment for alcohol dependence', Pharmacogenetics and Genomics, vol. 21, no. 12, pp. 902-905. 40 34
2011	Irvine, RJ, Kostakis, C, Felgate, PD, Jaehne, EJ, Chen, C & White, JM 2011, 'Population drug use in Australia: a wastewater analysis', Forensic Science International, vol. 210, no. 1-3, pp. 69-73. Open access 134 126
2011	Majumder, I, White, JM & Irvine, RJ 2011, 'Antidepressant-like effects of 3,4-methylenedioxymethamphetamine in an animal model of depression', Behavioural Pharmacology, vol. 22, no. 8, pp. 758-765. 12 12
2011	Morefield, KM, Keane, M, Felgate, P, White, JM & Irvine, RJ 2011, 'Pill content, dose and resulting plasma concentrations of 3,4-methylendioxymethamphetamine (MDMA) in recreational 'ecstasy' users', Addiction, vol. 106, no. 7, pp. 1293-1300. 55 51
2010	Hay, JL, Kaboutari, J, White, JM, Salem, A & Irvine, R 2010, 'Model of methadone-induced hyperalgesia in rats and effect of memantine', European Journal of Pharmacology, vol. 626, no. 2-3, pp. 229-233. 15 13
2010	Longo, M, Wickes, W, Smout, M, Harrison, S, Cahill, C & White, JM 2010, 'Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence', Addiction, vol. 105, no. 1, pp. 146-154. 106 86
2010	Smout, M, Longo, M, Harrison, S, Minniti, R, Cahill, S, Wickes, W & White, JM 2010, 'The Psychostimulant Check-Up: a pilot study of a brief intervention to reduce illicit stimulant use', Drug and Alcohol Review, vol. 29, no. 2, pp. 169-176. Open access 5 4
2010	Smout, MF, Longo, M, Harrison, S, Minniti, R, Wickes, W & White, JM 2010, 'Psychosocial treatment for methamphetamine use disorders: a preliminary randomized controlled trial of cognitive behavior therapy and acceptance and commitment therapy', Substance Abuse, vol. 31, no. 2, pp. 98-107. 99 82
2010	Whitham, JN, Spurrier, NJ, Sawyer, MG, Baghurst, PA, Taplin, JE, White, JM & Gordon, AL 2010, 'The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials', Neurotoxicology and Teratology, vol. 32, no. 2, pp. 280-288. 49 42
2009	Hay, JL, White, JM, Bochner, F, Somogyi, AA, Semple, TJ & Rounsefell, B 2009, 'Hyperalgesia in opioid-managed chronic pain and opioid-dependent patients', Journal of Pain, vol. 10, no. 3, pp. 316-322. 139 114
2009	Liu, L, Hutchinson, MR, White, JM, Somogyi, AA & Coller, JK 2009, 'Association of IL-1B genetic polymorphisms with an increased risk of opioid and alcohol dependence', Pharmacogenetics and Genomics, vol. 19, no. 11, pp. 869-876. 42 38
2009	White, J, Bell, J, Saunders, JB, Williamson, P, Makowska, M, Farquharson, A & Beebe, KL 2009, 'Open-label dose-finding trial of buprenorphine implants (Probuphine)® for treatment of heroin dependence', Drug and Alcohol Dependence, vol. 103, no. 1-2, pp. 37-43. 67 54
2008	Bochner, F, White, JM, Somogyi, A & Hay, J 2008, 'Antinociceptive effects of high dose remifentanil in male methadone-maintained patients ', European Journal of Pain, vol. 12, no. 7, pp. 926-933. 19 15
2008	Cahill, S, Longo, M, White, JM, Mitchell, A, Srisurapanont, M & McGregor, c 2008, 'Psychometric evaluation of the Amphetamine Cessation Symptom Assessment ', Journal of Substance Abuse Treatment, vol. 34, no. 4, pp. 443-449. 37 30
2008	Gibson, A, Mattick, R, Degenhardt, L, White, JM, Ali, R & O'Brien, S 2008, 'Exposure to opioid maintenance treatment reduces long-term mortality ', Addiction, vol. 103, no. 3, pp. 462-468. 163 155
2008	Hotham, ED, White, J, Ali, R & Robinson, J 2008, 'Pregnancy-related changes in tobacco, alcohol and cannabis use reported by antenatal patients at two public hospitals in South Australia.', Australian and New Zealand Journal of Obstetrics and Gynaecology, vol. 48, no. 3, pp. 248-254. 41 36
2008	Mitchell, A, Srisurapanont, M, Wickes, W, McGregor, c & White, JM 2008, 'Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: A comparison of mirtazapine and modafinil with treatment as usual ', Journal of Substance Abuse Treatment, vol. 35, no. 3, pp. 334-342. 70 59
2008	Somogyi, A, White, JM, Larsen, M, Ali, R, Jittiwutikarn, J & Abadi, R 2008, 'Flexible dosing of Tincture of Opium in the management of opioid withdrawal: Pharmacokinetics and pharmacodynamics ', British Journal of Clinical Pharmacology, vol. 66, no. 5, pp. 640-647. Open access 18 19
2008	Tiihonen, J, Vocci, F, Hanson, G, White, JM, Elkashef, A & Wickes, W 2008, 'Pharmacotherapy of methamphetamine addiction: An update ', Substance Abuse, vol. 29, no. 3, pp. 31-49. Open access 109 98
2008	White, JM, Bochner, F, La Vincente, S, Chapleo, C & Somogyi, A 2008, 'Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects ', Clinical Pharmacology and Therapeutics, vol. 83, no. 1, pp. 144-152. 28 19
2008	Yelland, L, White, JM, Sims, D, Salter, A & Burns, J 2008, 'Inter- and intra-subject variability in ethanol pharmacokinetic parameters: Effects of testing interval and dose ', Forensic Science International, vol. 175, no. 1, pp. 65-72. 12 9

Non Traditional Outputs

Year	Output
2022	Todd, G, Davis, M, Bogomolova, S, White, J, Esterman, A & Kovac, S 2022, 'Don't let meth take hold' health campaign, 'Don't let meth take hold' campaign, SA, Australia, 17/10/2022-31/01/2023. Open access

Reports

Year	Output
2024	Tscharke, B, Bade, R, O'Brien, J, Prasad, P, Barry, D, Elisei, G, Reeks, T, Thomas, K, Mueller, J, Jaunay, E, Ghetia, M, Paxton, S, Simpson, B, White, J & Gerber, C 2024, National wastewater drug monitoring program report 21, Australian Criminal Intelligence Commission, Australia. Open access
2024	Tscharke, B, Verhagen, R, Bade, R, O'Brien, J, Prasad, P, Barry, D, Marano, K, Elisei, G, Reeks, T, Thai, P, Thomas, K, Mueller, J, Keller, E, Ghetia, M, Paxton, S, Simpson, B, White, J & Gerber, C 2024, National Wastewater Drug Monitoring Program - report 23, Australian Criminal Intelligence Commission, Australia. Open access
2024	Tscharke, B, Verhagen, R, Bade, R, O'Brien, J, Prasad, P, Barry, D, Marano, K, Elisei, G, Reeks, T, Thai, P, Thomas, K, Mueller, J, Keller, E, Ghetia, M, Paxton, S, Simpson, B, White, J & Gerber, C 2024, National Wastewater Drug Monitoring Program: report 22, Australian Criminal Intelligence Commission, Australia. Open access
2023	Tscharke, B, Bade, R, O'Brien, J, Prasad, P, Barry, D, Elisei, G, Reeks, T, Bowman, J, Thomas, K, Mueller, J, Ghetia, M, Jaunay, E, Paxton, S, Paxton, K, Simpson, B, White, J & Gerber, C 2023, National wastewater drug monitoring program - report 18, Australian Criminal Intelligence Commission, Australia. Open access
2023	Tscharke, B, O'Brien, J, Bade, R, Prasad, P, Barry, D, Elisei, G, Reeks, T, Bowman, J, Thomas, K, Mueller, J, Ghetia, M, Jaunay, E, Paxton, S, Paxton, K, Simpson, B, White, J & Gerber, C 2023, National wastewater drug monitoring program - report 19, Australian Criminal Intelligence Commission, Australia. Open access
2023	Tscharke, B, O'Brien, J, Bade, R, Prasad, P, Barry, D, Elisei, G, Reeks, T, Thomas, K, Mueller, J, Jaunay, E, Ghetia, M, Paxton, S, Paxton, K, Simpson, B, White, J & Gerber, C 2023, National wastewater drug monitoring program Report 20, Australian Criminal Intelligence Commission, Australia. Open access
2022	Tscharke, B, Bade, R, O'Brien, J, Reeks, T, Prasad, P, Elisei, G, Barry, D, Alongi, C, Thomas, K, Mueller, J, Ghetia, M, Jaunay, E, Paxton, S, Simpson, B, White, J & Gerber, C 2022, National wastewater drug monitoring program - report 16, Australian Criminal Intelligence Commission, Australia. Open access
2022	Tscharke, B, O'Brien, J, Bade, R, Prasad, P, Barry, D, Elisei, G, Reeks, T, Thomas, K, Mueller, J, Ghetia, M, Jaunay, E, Paxton, S, Paxton, K, Simpson, B, White, J & Gerber, C 2022, National wastewater drug monitoring program - report 17, Australian Criminal Intelligence Commission, Australia. Open access
2022	Tscharke, B, O'Brien, J, Bade, R, Reeks, T, Prasad, P, Elisei, G, Sichani, H, Alongi, C, Mueller, J, Thomas, K, Ghetia, M, Jaunay, E, Paxton, S, Simpson, B, Gerber, C & White, J 2022, National wastewater drug monitoring program - report 15, Australian Criminal Intelligence Commission, Australia. Open access
2021	Tscharke, B, O'Brien, J, Bade, R, Reeks, T, Prasad, P, Elisei, G, Sichani, H, Mueller, J, Thomas, K, Ghetia, M, Adiraju, S, Rillo, J, Simpson, B, Gerber, C & White, J 2021, National wastewater drug monitoring program - report 14, Australian Criminal Intelligence Commission, Australia. Open access
2019	Tscharke, B, Mackie, R, O'Brien, J, Grant, S, Mueller, J, Ghetia, M, Aghera, H, Bade, R, Gerber, C & White, J 2019, National Wastewater Drug Monitoring Program: report 7, Australian Criminal Intelligence Commission, Australia. Open access
2019	Tscharke, B, Mackie, R, O'Brien, J, Grant, S, Mueller, J, Ghetia, M, Aghera, H, Bade, R, Gerber, C & White, J 2019, National Wastewater Drug Monitoring Program: report 8, Australian Criminal Intelligence Commission, Australia. Open access
2018	Tscharke, B, Mackie, R, O'Brien, J, Grant, S, Mueller, J, Ghetia, M, Aghera, H, Bade, R, Gerber, C & White, J 2018, National Wastewater Drug Monitoring Program: report 5, Australian Criminal Intelligence Commission, Australia. Open access
2018	Tscharke, B, Mackie, R, O'Brien, J, Grant, S, Mueller, J, Ghetia, M, Aghera, H, Bade, R, Gerber, C & White, J 2018, National Wastewater Drug Monitoring Program: report 6, Australian Criminal Intelligence Commission, Australia. Open access
2017	O'Brien, J, Grant, S, Mueller, J, Tscharke, B, Gerber, C & White, J 2017, National Wastewater Drug Monitoring Program: report 1, Australian Criminal Intelligence Commission, Australia. Open access
2017	Tscharke, B, Mackie, R, O'Brien, J, Grant, S, Mueller, J, Bade, R, Ghetia, M, Gerber, C & White, J 2017, National wastewater drug monitoring program: report 2, Australian Criminal Intelligence Commission, Australia. Open access
2017	Tscharke, B, Mackie, R, O'Brien, J, Grant, S, Mueller, J, Ghetia, M, Aghera, H, Bade, R, Gerber, C & White, J 2017, National Wastewater Drug Monitoring Program: report 3, Australian Criminal Intelligence Commission, Australia. Open access
2017	Tscharke, B, Mackie, R, O'Brien, J, Grant, S, Mueller, J, Ghetia, M, Aghera, H, Bade, R, Gerber, C & White, J 2017, National Wastewater Drug Monitoring Program: report 4, Australian Criminal Intelligence Commission, Australia. Open access

Research

Current research & highlights

My research focuses on the pharmacology of drugs of dependence, particularly opioids and stimulants. We have a laboratory to measure physiological, behavioural and cognitive function in human subjects, both volunteers and clinical populations. The clinical groups include people being treated for drug dependence and pain patients who are prescribed opioids. We also conduct clinical trials in these populations at treatment centres in Adelaide.Our research has two main aims. The first is to characterise the adverse effects of long term use of opioids and stimulant drugs. For example, we have shown that prolonged opioid use in the context of either pain treatment or addiction increases sensitivity to some types of painful stimuli. This opioid-induced hyperalgesia may play an important role in maintaining long term patterns of opioid use. In future research we will examining the factors that predict the degree of hyperalgesia (eg pharmacogenetic factors) and pharmacological strategies to reduce hyperalgesia. Another project involves collaboration with cognitive psychologists to characterise the impairment in function arising from chronic opioid use and the relative effects of partial and full agonists. The second aim is to improve current treatments for drug dependence and pain. Several strategies are being used. One is to improve medication adherence and reduce the variation due to pharmacokinetics by using long acting formulations of drugs currently employed in treatment. For example, we conducted the first trial of a buprenorphine implant that provided therapeutic concentrations of the drug over a 6 month period. A second strategy has been to trial novel drug combinations. For example, we showed the efficacy of combinations of buprenorphine with ultra-low doses of opioid antagonists. This was the first definitive study to demonstrate that a combination shown in animal models to reduce opioid requirements and decrease the development of tolerance was also effective in humans. We have also used pharmacogenetic approaches to examine how opioids can best be used to minimise risks of dependence.

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Allwater	AUSTRALIA
Arizona State University	UNITED STATES
Association of Child Care Centres of SA Inc	AUSTRALIA
Centre for Treatment of Anxiety Disorders	AUSTRALIA
Chiang Mai University	THAILAND
Curtin University	AUSTRALIA
Dalian Maritime University	CHINA
Department of Defence	AUSTRALIA
Drug and Alcohol Services SA	AUSTRALIA
ESR - Christchurch Science Centre	NEW ZEALAND
European Monitoring Centre on Drugs and Drug Addiction	PORTUGAL
Flinders Medical Centre	AUSTRALIA
Flinders University	AUSTRALIA
Forensic Science SA	AUSTRALIA
Ghent University	BELGIUM
Goethe University Frankfurt	GERMANY
Grenoble Alpes University	FRANCE
Griffith University	AUSTRALIA
Hunter New England Local Health District	AUSTRALIA
Institute of Environmental Science and Research	NEW ZEALAND
Istituto di Ricerche Farmacologiche Mario Negri	ITALY
Jaume I University	SPAIN
King's College London	UNITED KINGDOM
KWPX	AUSTRALIA
KWR Water Research Institute	NETHERLANDS
Lyell McEwin Hospital	AUSTRALIA
Monash University	AUSTRALIA
National Drug and Alcohol Research Centre	AUSTRALIA
National Institute on Drug Abuse	UNITED STATES
Neuroscience Research Australia	AUSTRALIA
Norwegian Institute for Water Research	NORWAY
Queensland Health	AUSTRALIA
Queensland University of Technology	AUSTRALIA
Royal Adelaide Hospital	AUSTRALIA
Royal Brisbane and Women's Hospital	AUSTRALIA
SA Pathology	AUSTRALIA
South Western Sydney Area Health Service	AUSTRALIA
St Vincent's Hospital	AUSTRALIA
The Byrne Surgery, Specialist Drug and Alcohol Practice, Redfern, New South Wales	AUSTRALIA
The Queen Elizabeth Hospital	AUSTRALIA
Titan Pharmaceuticals	UNITED STATES
Universitat Jaume I	SPAIN
University of Adelaide	AUSTRALIA
University of Antwerp	BELGIUM
University of Auckland	NEW ZEALAND
University of California	UNITED STATES
University of Colorado Denver	UNITED STATES
University of Copenhagen	DENMARK
University of Kuopio	FINLAND
University of Melbourne	AUSTRALIA
University of New South Wales	AUSTRALIA
University of Newcastle	AUSTRALIA
University of Puget Sound	UNITED STATES
University of Queensland	AUSTRALIA
University of Shahrekord	IRAN
University of South Australia	AUSTRALIA
University of Sydney	AUSTRALIA
University of Tasmania	AUSTRALIA
University of Tubingen	GERMANY
University of Utah	UNITED STATES
Walter Reed Army Institute for Research	UNITED STATES
Western Sydney Local Health District	AUSTRALIA
Women's and Children's Hospital	AUSTRALIA
World Health Organisation	SWITZERLAND

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Addressing the challenges for measuring population biomarkers and cannabinoids by wastewater-based epidemiology	Completed
Investigation of peripheral biomarkers for assessing operator alertness and attention during sleep loss	Completed
Population-scale drug use in Adelaide, South Australia, by wastewater analysis	Completed
Spatiotemporal study of stress biomarkers and benzodiazepines in Australian wastewater	Completed
The fate of opioids in wastewater treatment plants in Australia	Completed
The impact of genetic predictors of opioid dependence on neuroimmune and endocrine markers in healthy adults	Completed
The long-term effect of illicit stimulant use on movement	Completed

more less

Professor Jason White

About me

About me

UniSA Clinical & Health Sciences

About me

Professional Associations

Experience

Qualifications

Research

Research focus

Highlights

Projects

Other projects

Outputs

Chapters

Journal Articles

Non Traditional Outputs

Reports

Current research & highlights

External engagement & recognition

Collaborations

Collaborations

Teaching & student supervision

Courses and programs

Research degree supervision

Gallery